Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 583
Selected: 0
NCT IDTitle
NCT02644291Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
NCT02575222Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma
NCT02146937A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance
NCT01203722Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
NCT00022724CCI-779 in Treating Patients With Malignant Glioma
NCT05081193Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
NCT00015925MS-275 in Treating Patients With Hematologic Cancer
NCT01282216Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
NCT00278200Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD
NCT02575794Terameprocol in Treating Patients With Recurrent High Grade Glioma
NCT02489357Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
NCT03843814Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma
NCT00002778Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT02396368A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer
NCT02463799Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC
NCT00390364Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
NCT00003616Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
NCT03420521Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors
NCT02370836Evaluating the Effects of Psycho-oncological Education on Distress and Quality of Life in Solid Tumor Cancer Patients
NCT06782932Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
NCT03603002Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer
NCT04116073INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer
NCT03043794Study of Stereotactic Radiotherapy for Breast Cancer
NCT00971737Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
NCT00559429Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
NCT04848116Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca
NCT03707444A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer
NCT00364364Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.
NCT06315257A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
NCT03965494AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
NCT07142551Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
NCT03542773Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET
NCT04177810Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer
NCT01417182Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer
NCT04713046Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
NCT01715233Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
NCT03607890Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
NCT02151760Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer
NCT06610682Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib
NCT00809276Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY
NCT00006355Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
NCT04117074Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery
NCT00343447Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia
NCT00274768Capecitabine in Treating Patients With Metastatic Breast Cancer
NCT02680587Stereotactic Body Radiation for Prostate Oligometastases
NCT00539318Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
NCT00133991Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia
NCT02981524Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
NCT00348088Melanoma Biomarker Study
NCT04895553Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban